OptimizeRx Corp — Revenue by Fiscal Year
16 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c63cc9ec-dcd8-4c35-8953-c9bb8be5ac7c/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $109.4M | 2025-01-01 – 2025-12-31 | evidence 0001448431-26-000005 |
| FY 2024 | $92.1M | 2024-01-01 – 2024-12-31 | evidence 0001448431-26-000005 |
| FY 2023 | $71.5M | 2023-01-01 – 2023-12-31 | evidence 0001213900-25-025576 |
| FY 2022 | $62.5M | 2022-01-01 – 2022-12-31 | evidence 0001213900-24-033000 |
| FY 2021 | $4.5M | 2021-01-01 – 2021-12-31 | evidence 0001213900-23-019233 |
| FY 2020 | $43.3M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-013996 |
| FY 2019 | $24.6M | 2019-01-01 – 2019-12-31 | evidence 0001213900-20-007491 |
| FY 2018 | $21.2M | 2018-01-01 – 2018-12-31 | evidence 0001213900-19-003962 |
| FY 2017 | $12.1M | 2017-01-01 – 2017-12-31 | evidence 0001213900-19-003962 |
| FY 2016 | $6.2M | 2016-01-01 – 2016-12-31 | evidence 0001213900-18-002722 |
| FY 2015 | $7.2M | 2015-01-01 – 2015-12-31 | evidence 0001213900-16-011609 |
| FY 2014 | $6.5M | 2014-01-01 – 2014-12-31 | evidence 0001213900-15-002228 |
| FY 2013 | $4.7M | 2013-01-01 – 2013-12-31 | evidence 0001213900-15-002228 |
| FY 2012 | $2.0M | 2012-01-01 – 2012-12-31 | evidence 0001255294-14-000254 |
| FY 2011 | $1.1M | 2011-01-01 – 2011-12-31 | evidence 0001255294-12-000205 |
| FY 2010 | $71.1k | 2010-01-01 – 2010-12-31 | evidence 0001255294-12-000205 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).